Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Reproductive health and endocrine disruption in women with breast cancer: a pilot study.

Patel A, Roston A, Uy A, Radeke E, Roston A, Keith L, Zaren HA.

Support Care Cancer. 2015 Feb;23(2):411-8. doi: 10.1007/s00520-014-2381-2. Epub 2014 Aug 15.

PMID:
25120011
2.

Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.

Tiong V, Rozita AM, Taib NA, Yip CH, Ng CH.

World J Surg. 2014 Sep;38(9):2288-96. doi: 10.1007/s00268-014-2542-y.

PMID:
24700093
3.
4.

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.

Reh A, Oktem O, Oktay K.

Fertil Steril. 2008 Nov;90(5):1635-9. doi: 10.1016/j.fertnstert.2007.09.048. Epub 2007 Dec 31.

PMID:
18166178
5.

[Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].

Li HP, Ma LW, Zhang SL, Jia TZ, Deng HJ, Zhang ZH, Liang L, Wang MP, Xiao Y, Cao BS, Chen S, Wang YF.

Zhonghua Zhong Liu Za Zhi. 2006 Nov;28(11):848-51. Chinese.

PMID:
17416008
6.

Reproductive health assessment for women with cancer: a pilot study.

Patel A, Sreedevi M, Malapati R, Sutaria R, Schoenhage MB, Patel AR, Radeke EK, Zaren HA.

Am J Obstet Gynecol. 2009 Aug;201(2):191.e1-4. doi: 10.1016/j.ajog.2009.04.021. Epub 2009 Jun 18.

PMID:
19539896
7.

Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women.

Santoro N, Arnsten JH, Buono D, Howard AA, Schoenbaum EE.

J Womens Health (Larchmt). 2005 Dec;14(10):898-905.

PMID:
16372891
8.

Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy.

Yu B, Douglas N, Ferin MJ, Nakhuda GS, Crew K, Lobo RA, Hershman DL.

Cancer. 2010 May 1;116(9):2099-105. doi: 10.1002/cncr.25037.

9.

Contraception for the older woman.

Glasier A, Gebbie A.

Baillieres Clin Obstet Gynaecol. 1996 Apr;10(1):121-38. Review.

PMID:
8736726
10.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

Meirow D, Raanani H, Maman E, Paluch-Shimon S, Shapira M, Cohen Y, Kuchuk I, Hourvitz A, Levron J, Mozer-Mendel M, Brengauz M, Biderman H, Manela D, Catane R, Dor J, Orvieto R, Kaufman B.

Fertil Steril. 2014 Aug;102(2):488-495.e3. doi: 10.1016/j.fertnstert.2014.05.017. Epub 2014 Jun 14.

PMID:
24934489
11.

Chemotherapy-related amenorrhea in premenopausal women with breast cancer.

Lee S, Kil WJ, Chun M, Jung YS, Kang SY, Kang SH, Oh YT.

Menopause. 2009 Jan-Feb;16(1):98-103. doi: 10.1097/gme.0b013e3181844877.

PMID:
18849877
12.

Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus.

Short RV, Lewis PR, Renfree MB, Shaw G.

Lancet. 1991 Mar 23;337(8743):715-7.

PMID:
1672186
13.

New IPPF statement on breastfeeding, fertility and post-partum contraception.

International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP.

IPPF Med Bull. 1990 Apr;24(2):2-4.

PMID:
12316285
14.

Contraceptive efficacy of lactational amenorrhoea.

Kennedy KI, Visness CM.

Lancet. 1992 Jan 25;339(8787):227-30.

PMID:
1346183
15.

Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.

Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, Naftalis E, Naughton MJ.

Cancer. 2010 Jul 1;116(13):3102-11. doi: 10.1002/cncr.25106.

16.

Ovarian function and childbearing issues in breast cancer survivors.

Gadducci A, Cosio S, Genazzani AR.

Gynecol Endocrinol. 2007 Nov;23(11):625-31. Review.

PMID:
17926162
17.

Hormone testing in women with adult-onset amenorrhea.

Laufer MR, Floor AE, Parsons KE, Kuntz KM, Barbieri RL.

Gynecol Obstet Invest. 1995;40(3):200-3.

PMID:
8529955
18.

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.

Badawy A, Elnashar A, El-Ashry M, Shahat M.

Fertil Steril. 2009 Mar;91(3):694-7. doi: 10.1016/j.fertnstert.2007.12.044. Epub 2008 Aug 3.

PMID:
18675959
19.

Fertility Preservation for the Young Breast Cancer Patient.

Goldfarb SB, Kamer SA, Oppong BA, Eaton A, Patil S, Junqueira MJ, Olcese C, Kelvin JF, Gemignani ML.

Ann Surg Oncol. 2016 May;23(5):1530-6. doi: 10.1245/s10434-015-5036-8. Epub 2016 Jan 20.

20.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024

Supplemental Content

Support Center